McGuireWoods Richmond associate Heidi Siegmund and partner Davis Walsh were quoted in a Feb. 26, 2021, TechRepublic article about the sluggish return of business travel.
Factoring in the vaccine rollout, a productive year of remote work and associated cost-savings for many companies, it is unclear if and when travel will resume at pre-COVID-19 frequency.
Employee comfort is also a principal focus. Siegmund noted that travel should be evaluated on a case-by-case basis to accommodate individual medical conditions.
Because health and safety regulations, including testing and quarantine rules, vary geographically, Walsh said “employers will need to consider the health and safety requirements for not only an employee’s home base but also the places where they will be traveling.”
Walsh and McGuireWoods partner Samuel Tarry are editors of “Infectious Disease Litigation: Science, Law & Procedure,” published by the American Bar Association in February 2021. The book provides practical guidance for handling infectious disease litigation, from COVID-19 pandemic disputes to matters related to localized outbreaks that require specialized knowledge.